Compare Edwards Lifesciences Corporation Common Stock (EW) vs iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs iShares iBoxx $ Inv Grade Corporate Bond ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $102.47 (market cap $27.76B). The key difference: Edwards Lifesciences Corporation Common Stock is the larger of the two by market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, iShares iBoxx $ Inv Grade Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| EW | LQD | |
|---|---|---|
Market Cap | $49.44B | $27.76B |
Volume | 3,508,027 | 30,088,564 |
Sector | Health | Fixed Income |
52-Week High | $95.18 | $112.91 |
52-Week Low | $72.65 | $101.83 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 125 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LQD trades at $102.12, down 0.02% on the day, amid a bearish technical signal with moving averages indicating selling pressure and oscillators neutral. The ETF faces headwinds from rising bond yields and a significant 53.1% increase in short interest reported as of September 15, 2026. Recent dividends include $0.44 and $0.46 payouts scheduled through October 2026, providing income support.
Outlook remains cautious due to persistent bond market volatility and higher interest rates, which pressure corporate bond ETFs. Investment opportunities lie in the 4.8% yield and high-quality portfolio, but risks include further yield spikes and economic slowdowns affecting credit quality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →
